Studying dialysis fluid to find markers of abdominal scarring
Part of Digestive system clinical trials.
This study examines fluid from your dialysis to find early warning signs of scarring in the abdominal lining (peritoneal fibrosis). The goal is to help doctors detect and manage this condition better for people on peritoneal dialysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You are either on peritoneal dialysis for more than 3 months, on hemodialysis for more than 3 months and planning a kidney transplant, or have normal kidney function and are scheduled for hernia repair surgery.
- If you are on peritoneal dialysis, you have not had peritonitis (an infection of the abdominal lining) in the past 3 months.
- You have no history of abdominal tumors that have spread to the lining of the abdomen.
- You are willing to sign a consent form to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a protein called DKK3 in the fluid that drains from your belly during peritoneal dialysis. The goal is to see if this protein can help predict early scarring (fibrosis) of the belly lining, so doctors can monitor and treat problems sooner.
This study is testing a new computer tool that helps doctors see how well peritoneal dialysis (a type of kidney treatment done at home) removes waste from your body. It may help make your dialysis more effective.
This study collects samples from the belly (related to the peritoneal lining) to build a “biobank” for future research. It may help patients and families by improving understanding of kidney disease and kidney dialysis-related health issues.
This trial tests if canagliflozin, a diabetes medicine, helps remove extra fluid and reduce scarring in people on peritoneal dialysis (home-based dialysis). It may improve your dialysis results and protect your belly lining.
This study uses a special PET/CT scan to look for scarring in the kidneys. The goal is to see if the scan can detect kidney fibrosis better than current methods.
This trial uses a special PET/CT scan to look at kidney scarring (fibrosis) in people with chronic kidney disease. It could help doctors monitor kidney damage without needing a biopsy.
Hear when a new Peritoneal Dialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.